2.4 mg semaglutide weekly Efficacy and safety of once-weekly 2·4 versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial Semaglutide 2.4 mg Injection at Wegovy (Semaglutide) Weight Loss Injector 2.4 mg/0.75 mL is a prescription medication that contains the active ingredient semaglutide Wegovy weight-loss pill now available
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





























